123 related articles for article (PubMed ID: 15195079)
1. Treatment of menorrhagia in women undergoing hematopoietic stem cell transplantation.
Amsterdam A; Jakubowski A; Castro-Malaspina H; Baxi E; Kauff N; Krychman M; Stier E; Castiel M
Bone Marrow Transplant; 2004 Aug; 34(4):363-6. PubMed ID: 15195079
[TBL] [Abstract][Full Text] [Related]
2. Prevention of severe menorrhagia in oncology patients with treatment-induced thrombocytopenia by luteinizing hormone-releasing hormone agonist and depo-medroxyprogesterone acetate.
Meirow D; Rabinovici J; Katz D; Or R; Shufaro Y; Ben-Yehuda D
Cancer; 2006 Oct; 107(7):1634-41. PubMed ID: 16944540
[TBL] [Abstract][Full Text] [Related]
3. The treatment of menorrhagia in female stem cell transplant recipients.
Sica S; Sorà F; Laurenti L; Chiusolo P; Piccirillo N; Scirpa P; Leone G
Bone Marrow Transplant; 2005 Apr; 35(8):827. PubMed ID: 15750605
[No Abstract] [Full Text] [Related]
4. Alloreactivity as therapeutic principle in the treatment of hematologic malignancies. Studies of clinical and immunologic aspects of allogeneic hematopoietic cell transplantation with nonmyeloablative conditioning.
Petersen SL
Dan Med Bull; 2007 May; 54(2):112-39. PubMed ID: 17521527
[TBL] [Abstract][Full Text] [Related]
5. Optimal initial dose of oral cyclosporine in relation to its toxicities for graft-versus-host disease prophylaxis following reduced-intensity stem cell transplantation in Japanese patients.
Kishi Y; Murashige N; Kami M; Miyakoshi S; Shibagaki Y; Hamaki T; Takaue Y; Taniguchi S;
Bone Marrow Transplant; 2005 Jun; 35(11):1079-82. PubMed ID: 15806118
[TBL] [Abstract][Full Text] [Related]
6. The role and impact of the transfusion medicine consultation service in the management of patients in the hematopoietic transplant service: A retrospective analysis.
Narvios A; Rodriguez-Jackson L; Reddy V; Lichtiger B
Transfus Clin Biol; 2009 Sep; 16(4):383-7. PubMed ID: 19665413
[TBL] [Abstract][Full Text] [Related]
7. Hormonal replacement therapy after stem cell transplantation.
Piccioni P; Scirpa P; D'Emilio I; Sora F; Scarciglia M; Laurenti L; De Matteis S; Sica S; Leone G; Chiusolo P
Maturitas; 2004 Dec; 49(4):327-33. PubMed ID: 15531129
[TBL] [Abstract][Full Text] [Related]
8. Role of tranexamic acid in management of dysfunctional uterine bleeding in comparison with medroxyprogesterone acetate.
Kriplani A; Kulshrestha V; Agarwal N; Diwakar S
J Obstet Gynaecol; 2006 Oct; 26(7):673-8. PubMed ID: 17071438
[TBL] [Abstract][Full Text] [Related]
9. Predictive factors for survival in myeloma patients who undergo autologous stem cell transplantation: a single-centre experience in 211 patients.
O'Shea D; Giles C; Terpos E; Perz J; Politou M; Sana V; Naresh K; Lampert I; Samson D; Narat S; Kanfer E; Olavarria E; Apperley JF; Rahemtulla A
Bone Marrow Transplant; 2006 Apr; 37(8):731-7. PubMed ID: 16501593
[TBL] [Abstract][Full Text] [Related]
10. Maintenance therapy with thalidomide improves overall survival after autologous hematopoietic progenitor cell transplantation for multiple myeloma.
Brinker BT; Waller EK; Leong T; Heffner LT; Redei I; Langston AA; Lonial S
Cancer; 2006 May; 106(10):2171-80. PubMed ID: 16598756
[TBL] [Abstract][Full Text] [Related]
11. Long-term follow-up of allogeneic hematopoietic stem cell transplantation for de novo acute myelogenous leukemia with a conditioning regimen of total body irradiation and granulocyte colony-stimulating factor-combined high-dose cytarabine.
Mori T; Aisa Y; Watanabe R; Yamazaki R; Kato J; Shimizu T; Shigematsu N; Kubo A; Yajima T; Hibi T; Ikeda Y; Okamoto S
Biol Blood Marrow Transplant; 2008 Jun; 14(6):651-7. PubMed ID: 18489990
[TBL] [Abstract][Full Text] [Related]
12. The role of ERCP in patients with pancreatico-biliary problems in the setting of hematopoietic stem cell transplant.
Alnusair MM; DeMagalhaes-Silverman M; Silverman WB
Gastrointest Endosc; 2006 Apr; 63(4):655-9. PubMed ID: 16564868
[TBL] [Abstract][Full Text] [Related]
13. Allogeneic hematopoietic stem cell transplantation with a reduced-intensity conditioning regimen for treatment of metastatic renal cell carcinoma: single institution experience with a minimum 1-year follow-up.
Nakagawa T; Kami M; Hori A; Kim SW; Murashige N; Hamaki T; Kishi Y; Fujimoto H; Matsuoka N; Okajima E; Komiyama M; Tobisu K; Wakayama T; Uike N; Tajima K; Makimoto A; Mori S; Tanosaki R; Takaue Y; Kakizoe T
Exp Hematol; 2004 Jul; 32(7):599-606. PubMed ID: 15246155
[TBL] [Abstract][Full Text] [Related]
14. [Allogeneic hematopoietic stem cell transplantation in patients with chronic myeloid leukemia in the Czech Republic--a retrospective analysis of results in years 1988-2005].
Faber E; Koza V; Vítek A; Mayer J; Sedlácek P; Zák P; Zapletalová J; Benesová K; Krejcová H; Steinerová K; Maresová I; Cetkovský P
Vnitr Lek; 2006 Dec; 52(12):1172-80. PubMed ID: 17299910
[TBL] [Abstract][Full Text] [Related]
15. Disease burden may identify patients more likely to benefit from second allogeneic hematopoietic stem cell transplantation to treat relapsed acute myelogenous leukemia.
Hosing C; Saliba RM; Shahjahan M; Estey EH; Couriel D; Giralt S; Andersson B; Champlin RE; De Lima M
Bone Marrow Transplant; 2005 Jul; 36(2):157-62. PubMed ID: 15937511
[TBL] [Abstract][Full Text] [Related]
16. Home administration of high-dose oral busulfan in patients undergoing hematopoietic stem cell transplantation.
Matthews RH; Emami M; Connaghan DG; Holland HK; Morris LE
Bone Marrow Transplant; 2007 Apr; 39(7):397-400. PubMed ID: 17322933
[TBL] [Abstract][Full Text] [Related]
17. Allogeneic stem cell transplantation for adults with myelodysplastic syndromes: importance of pretransplant disease burden.
Warlick ED; Cioc A; Defor T; Dolan M; Weisdorf D
Biol Blood Marrow Transplant; 2009 Jan; 15(1):30-8. PubMed ID: 19135940
[TBL] [Abstract][Full Text] [Related]
18. Results of a retrospective single institution analysis of targeted skeletal radiotherapy with (166)Holmium-DOTMP as conditioning regimen for autologous stem cell transplant for patients with multiple myeloma. Impact on transplant outcomes.
Christoforidou AV; Saliba RM; Williams P; Qazilbash M; Roden L; Aleman A; Weber D; Mendoza F; Podoloff D; Wendt R; Breitz H; Alexanian R; Champlin R; Giralt S
Biol Blood Marrow Transplant; 2007 May; 13(5):543-9. PubMed ID: 17448913
[TBL] [Abstract][Full Text] [Related]
19. Cytomegalovirus antigenemia and outcomes of patients undergoing allogeneic peripheral blood stem cell transplantation: effects of long-term high-dose acyclovir prophylaxis and preemptive ganciclovir treatment.
Hazar V; Ugur A; Colak D; Saba R; Tezcan G; Kupesiz A; Karadogan I; Gultekin M; Yesilipek A; Undar L
Jpn J Infect Dis; 2006 Aug; 59(4):216-21. PubMed ID: 16936338
[TBL] [Abstract][Full Text] [Related]
20. Management of menorrhagia in women with inherited bleeding disorders: general principles and use of desmopressin.
Rodeghiero F
Haemophilia; 2008 Jan; 14 Suppl 1():21-30. PubMed ID: 18173691
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
